Paper40344640
Rational Design of Inner Ear Drug Delivery Systems.
Maimaitikelimu X and 5 others. Adv Sci (Weinh), 2025. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Rational Design of Inner Ear Drug Delivery Systems. Papers, record 40344640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40344640
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Delivery Systems | Major topic |
| Ear, Inner | Major topic |
| Hearing Loss, Sensorineural | Major topic |
| Humans | |
| Animals |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82471164 | National Natural Science Foundation of China | PubMed | ||
| 22302231 | National Natural Science Foundation of China | PubMed | ||
| 823B2021 | National Natural Science Foundation of China | PubMed | ||
| B2401007 | Shenzhen Medical Research Fund | PubMed | ||
| JCYJ20220530144201002 | Shenzhen Science and Technology Program | PubMed | ||
| FTWS2022013 | Futian Healthcare Research Project | PubMed | ||
| FTWS2023080 | Futian Healthcare Research Project | PubMed | ||
| YXYXCXRC202109 | Sun Yat-sen Eighth Affiliated Hospital Excellent Medical Innovative Talents Program | PubMed | ||
| 2023A1515011986 | Basic and Applied Basic Research Foundation of Guangdong Province | PubMed |
Source PubMed
References232
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27788219 | Improved Auditory Nerve Survival with Nanoengineered Supraparticles for Neurotrophin Delivery into the Deafened Cochlea. | PLoS One | 2016 | https://conductscience.org/library/papers/27788219 | PubMed |
| 2 | 33953438 | The world report on hearing, 2021. | Bull World Health Organ | 2021 | https://conductscience.org/library/papers/33953438 | PubMed |
| 3 | 21533919 | Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model. | Cancer Chemother Pharmacol | 2011 | https://conductscience.org/library/papers/21533919 | PubMed |
| 4 | 32725028 | A metal-organic framework based inner ear delivery system for the treatment of noise-induced hearing loss. | Nanoscale | 2020 | https://conductscience.org/library/papers/32725028 | PubMed |
| 5 | 37100013 | Piceatannol protects against age-related hearing loss by inhibiting cellular pyroptosis and inflammation through regulated Caspase11-GSDMD pathway. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37100013 | PubMed |
| 6 | 29514916 | CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss. | J Exp Med | 2018 | https://conductscience.org/library/papers/29514916 | PubMed |
| 7 | 34713249 | The Promise and the Hope of Gene Therapy. | Front Genome Ed | 2021 | https://conductscience.org/library/papers/34713249 | PubMed |
| 8 | 38345574 | Complete Restoration of Hearing Loss and Cochlear Synaptopathy via Minimally Invasive, Single-Dose, and Controllable Middle Ear Delivery of Brain-Derived Neurotrophic Factor-Poly(dl-lactic acid-co-glycolic acid)-Loaded Hydrogel. | ACS Nano | 2024 | https://conductscience.org/library/papers/38345574 | PubMed |
| 9 | 37441605 | Intrinsic mechanism and pharmacologic treatments of noise-induced hearing loss. | Theranostics | 2023 | https://conductscience.org/library/papers/37441605 | PubMed |
| 10 | 33133777 | Treatment of Inflammatory Diseases with IL-1 Blockade. | Curr Otorhinolaryngol Rep | 2018 | https://conductscience.org/library/papers/33133777 | PubMed |
| 11 | 36556073 | Extracellular Vesicles in Inner Ear Therapies-Pathophysiological, Manufacturing, and Clinical Considerations. | J Clin Med | 2022 | https://conductscience.org/library/papers/36556073 | PubMed |
| 12 | 21271594 | Principles of inner ear sustained release following intratympanic administration. | Laryngoscope | 2011 | https://conductscience.org/library/papers/21271594 | PubMed |
| 13 | 38514042 | Biotechnological Effects of Advanced Smart-Bile Acid Cyclodextrin-Based Nanogels for Ear Delivery and Treatment of Hearing Loss. | Adv Healthc Mater | 2024 | https://conductscience.org/library/papers/38514042 | PubMed |
| 14 | 32310224 | Exosome-mediated protection of auditory hair cells from ototoxic insults. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32310224 | PubMed |
| 15 | 36306608 | Therapeutics for hearing preservation and improvement of patient outcomes in cochlear implantation-Progress and possibilities. | Hear Res | 2022 | https://conductscience.org/library/papers/36306608 | PubMed |
| 16 | 29361217 | Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss. | J Med Chem | 2018 | https://conductscience.org/library/papers/29361217 | PubMed |
| 17 | 31741303 | Cochlear protein biomarkers as potential sites for targeted inner ear drug delivery. | Drug Deliv Transl Res | 2020 | https://conductscience.org/library/papers/31741303 | PubMed |
| 18 | 27714498 | Effect of a liposomal hyaluronic acid gel loaded with dexamethasone in a guinea pig model after manual or motorized cochlear implantation. | Eur Arch Otorhinolaryngol | 2017 | https://conductscience.org/library/papers/27714498 | PubMed |
| 19 | 12871655 | Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig. | Neuropharmacology | 2003 | https://conductscience.org/library/papers/12871655 | PubMed |
| 20 | 31338024 | Local Drug Delivery for Prevention of Hearing Loss. | Front Cell Neurosci | 2019 | https://conductscience.org/library/papers/31338024 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42631265 | Biodistribution and transport of intratympanically administered drugs in the inner ear using a porcine ex-vivo chamber model. | Mater Des | 2026 | https://conductscience.org/library/papers/42631265 | PubMed |
| 42630566 | Engineered Inner Ear Drug Delivery Systems for Hearing Loss Treatment. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/42630566 | PubMed |
| 42609130 | Imaging-identified round window niche veil and intratympanic therapy efficacy in sudden sensorineural hearing loss. | Ann Med | 2026 | https://conductscience.org/library/papers/42609130 | PubMed |
| 41737043 | How Effective are Exosomes in Overcoming Blood-Labyrinth Barrier in Sensorineural Hearing Loss? A Comprehensive Review of the Literature. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41737043 | PubMed |
| 41728072 | Exosome Augmentation Technologies for Drug Delivery and Disease Treatment: A Review. | Biomater Res | 2026 | https://conductscience.org/library/papers/41728072 | PubMed |
| 41466295 | Sentinels or saboteurs, the Janus face of cochlear-resident macrophages in hearing loss: spatiotemporal distribution, pathophysiological functions, and translational potential. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/41466295 | PubMed |
| 41438770 | PLGA nanoparticles in otoprotection and inner ear regeneration: a new frontier in nanomedicine for hearing disorders. | RSC Adv | 2025 | https://conductscience.org/library/papers/41438770 | PubMed |
| 40739932 | Recent Advances in Functionalized Nanoparticles for Targeted and Controlled Inner Ear Therapy via Localized Cochlear Delivery. | J Audiol Otol | 2025 | https://conductscience.org/library/papers/40739932 | PubMed |
| 40344640 | Rational Design of Inner Ear Drug Delivery Systems. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40344640 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40344640
GET https://conductscience.org/api/papers/v1/40344640/references?page=2